These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 26893065)

  • 61. Prescribing and drug costs in the province of Ontario.
    Lexchin J
    Int J Health Serv; 1992; 22(3):471-87. PubMed ID: 1644510
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Perceptions of the provision of drug information, pharmaceutical detailing and engagement with non-personal promotion at a large physicians network: a mixed-methods study.
    Hincapie A; Schlosser E; Damachi U; Neff E; Llambi L; Groves K; MacKinnon NJ
    BMJ Open; 2021 Jan; 11(1):e041098. PubMed ID: 33462098
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prescription of fixed dose combination drugs for diarrhoea.
    Chakrabarti A
    Indian J Med Ethics; 2007; 4(4):165-7. PubMed ID: 18630234
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The attitude and acceptability towards medical promotional tools and their influence on physicians' prescribing practices in Jordan and Iraq: a cross-sectional study.
    Ali KE; Naser AY; Al-Rousan R; Alwafi H; AbuAlhommos AK; Alsairafi ZK; Salawati EM; Samannodi M; Dairi MS
    BMC Health Serv Res; 2022 Jan; 22(1):105. PubMed ID: 35078461
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
    McCarthy M
    BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
    [No Abstract]   [Full Text] [Related]  

  • 66. Generic drug prescribing in central Saudi Arabia: perceptions and attitudes of physicians.
    Alghasham AA
    Ann Saudi Med; 2009; 29(1):24-9. PubMed ID: 19139616
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.
    Kravitz RL; Epstein RM; Feldman MD; Franz CE; Azari R; Wilkes MS; Hinton L; Franks P
    JAMA; 2005 Apr; 293(16):1995-2002. PubMed ID: 15855433
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmaceutical opioid marketing and physician prescribing behavior.
    Beilfuss S; Linde S
    Health Econ; 2021 Dec; 30(12):3159-3185. PubMed ID: 34562329
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Extent of physician-pharmaceutical industry interactions in low- and middle-income countries: a systematic review.
    Fadlallah R; Alkhaled L; Brax H; Nasser M; Rajabbik MH; Nass H; Kahale LA; Akl EA
    Eur J Public Health; 2018 Apr; 28(2):224-230. PubMed ID: 29165586
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Patient, Physician and Organizational Influences on Variation in Antipsychotic Prescribing Behavior.
    Tang Y; Chang CC; Lave JR; Gellad WF; Huskamp HA; Donohue JM
    J Ment Health Policy Econ; 2016 Mar; 19(1):45-59. PubMed ID: 27084793
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Report: Interactions and conflicts of interests between prescribers and medical sales representatives (MSRs) regarding prescribing and drug promotion practices in Karachi, Pakistan.
    Naqvi AA; Zehra F; Khan N; Ahmad R; McGarry K
    Pak J Pharm Sci; 2019 Mar; 32(2):687-695. PubMed ID: 31081784
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.
    Orlowski JP; Wateska L
    Chest; 1992 Jul; 102(1):270-3. PubMed ID: 1623766
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An innovative approach to educating medical students about pharmaceutical promotion.
    Wilkes MS; Hoffman JR
    Acad Med; 2001 Dec; 76(12):1271-7. PubMed ID: 11739058
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Perception and attitude of Korean physicians towards generic drugs.
    Ryu M; Kim J
    BMC Health Serv Res; 2017 Aug; 17(1):610. PubMed ID: 28851368
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development and Feasibility of an Academic Detailing Intervention to Improve Prescription Drug Monitoring Program Use Among Physicians.
    Barth KS; Ball S; Adams RS; Nikitin R; Wooten NR; Qureshi ZP; Larson MJ
    J Contin Educ Health Prof; 2017; 37(2):98-105. PubMed ID: 28562498
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sources of drug information and their influence on the prescribing behaviour of doctors in a teaching hospital in Ibadan, Nigeria.
    Oshikoya KA; Oreagba I; Adeyemi O
    Pan Afr Med J; 2011; 9():13. PubMed ID: 22145057
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Receipt of Promotional Payments at the Individual and Physician Network Level Associated with Higher Branded Antipsychotic Prescribing Rates.
    Hollands S
    Adm Policy Ment Health; 2020 Jan; 47(1):73-85. PubMed ID: 31515636
    [TBL] [Abstract][Full Text] [Related]  

  • 78. National survey on the attitudes of Canadian physicians towards drug-detailing by pharmaceutical representatives.
    Strang D; Gagnon M; Molloy W; Bedard M; Darzins P; Etchells E; Davidson W
    Ann R Coll Physicians Surg Can; 1996 Dec; 29(8):474-8. PubMed ID: 12380577
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of marketing interactions with medical trainees' knowledge about evidence-based prescribing: results from a national survey.
    Austad KE; Avorn J; Franklin JM; Campbell EG; Kesselheim AS
    JAMA Intern Med; 2014 Aug; 174(8):1283-90. PubMed ID: 24911123
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A physician survey of the effect of drug sample availability on physicians' behavior.
    Chew LD; O'Young TS; Hazlet TK; Bradley KA; Maynard C; Lessler DS
    J Gen Intern Med; 2000 Jul; 15(7):478-83. PubMed ID: 10940134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.